SCHEMBL3848804

SCHEMBL3848804

Cc1ccc(Cl)cc1NC(=O)c1ccccc1C(=O)c1ccc2n[c][nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.48
▸ LMNA P02545 6/20 0.47
▸ MAPT P10636 5/20 0.47
▸ POLB P06746 3/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ NPY1R P25929 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPY2R P49146 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.44
▸ KCNMA1 Q12791 1/20 0.44
▸ GAA P10253 1/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ HPGD P15428 1/20 0.43
▸ GBA1 P04062 1/20 0.43
▸ NR1H4 Q96RI1 1/20 0.42
▸ PPARG P37231 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4462942 0.83 FADS1 (0.49) LMNAMAPTRAB9ANPC1MEN1
SCHEMBL3855951 0.82 NPSR1 (0.48) NPSR1LMNAMAPTPOLBRAB9A
SCHEMBL2301152 0.81 RAF1 (0.57) NPSR1LMNAMAPTPOLBRAB9A
SCHEMBL4464511 0.80 MAPT (0.44) NPSR1LMNAMAPTRAB9AKDM4E
SCHEMBL4473204 0.80 NPC1 (0.41) NPSR1LMNAMAPTRAB9ANPC1
SCHEMBL3848659 0.79 MEN1 (0.52) NPSR1LMNAMAPTRAB9AKDM4E
SCHEMBL3850936 0.78 GPR35 (0.43) NPSR1MAPTRAB9AKDM4ENPC1
SCHEMBL1467642 0.78 NPSR1 (0.46) NPSR1LMNAMAPTPOLBRAB9A
SCHEMBL4459109 0.77 RAF1 (0.41) NPSR1LMNAMAPTPOLBKDM4E
SCHEMBL4470605 0.77 NPC1 (0.40) NPSR1MAPTPOLBRAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2101759-A1 METHODS OF USING MEK INHIBITORS Exelixis, Inc. (US) 2009-09-23 — — EP claimed
WO-2008076415-A1 METHODS OF USING MEK INHIBITORS EXELIXIS, INC. (US) 2008-06-26 — — WO claimed
EP-2101759-B1 METHODS OF USING MEK INHIBITORS EXELIXIS INC (US) 2018-10-10 — — EP disclosed
Send feedback